[Inhibition of sanguinarine on S180 subcutaneously implanted tumors in mice].

Objective: To investigate the inhibition of sanguinarine on S180 sarcoma in mice and the effect of angiogenesis.

Methods: S180 subcutaneous implanted tumor model mice were randomly divided into six groups: control group, cyclophosphamide (CTX) group, sanguinarine (10, 20 and 40 mg/kg) groups and combination group. The mice were sacrificed on the 10th day to measure the tumor weight and volumes, and caculate the tumor growth inhibition.